CD4 and infection: Furthermore, most of the patients (81.3%) correctly identified the eligible patients for CrAg screening based on CD4 count, and 75.5% of them correctly identified pre-emptive treatment as treatment of patients with serological or imaging evidence of infection even when clinical disease is absent.